Teva Investor Meeting December 11

Teva Investor Meeting December 11 
LUND, SWEDEN -- (Marketwire) -- 12/11/12 --  Active Biotech's (NASDAQ
OMX NORDIC: ACTI) partner Teva Pharmaceutical Industries Ltd. will
today Tuesday, December 11, 2012 at 12:00 p.m. ET (6:00 p.m. CET)
host an investor meeting. Teva has a license to develop and
commercialize Active Biotech's molecule laquinimod, and
this molecule
may be discussed during the meeting. For further information please
see Active Biotech AB (publ) 

Tomas Leanderson
President & CEO

Active Biotech AB (NASDAQ OMX NORDIC: ACTI) is a biotechnology company
with focus on autoimmune/inflammatory diseases and cancer. Projects in
or entering
pivotal phase are laquinimod, an orally administered small
molecule with unique
immunomodulatory properties for the treatment of
multiple sclerosis, TASQ for
prostate cancer as well as ANYARA for
use in cancer targeted therapy, primarily
of renal cell cancer. In
addition, laquinimod is in Phase II development for
Crohn's and
Lupus. An additional project in clinical development is the
administered compound 57-57 for Systemic Sclerosis. Please
visit for more information. 

Active Biotech AB (Corp. Reg. No. 556223-9227)
Box 724, SE-220 07 Lund
Tel: +46 46 19 20 00
Fax: +46 46 19 11 00

Active Biotech is obligated to publish the information contained in
this press
release in accordance with the Swedish Securities Market
Act. This information
was provided to the media for publication 8:30
a.m. CET on December 11, 2012. 
Teva Investor Meeting December 11: 
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants
(i) the releases contained herein are protected by copyright and
other applicable laws; and 
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein. 
Source: Active Biotech via Thomson Reuters ONE 
For further information, please contact:
Hans Kolam
Phone: +46 (0)46 19 20 44
Press spacebar to pause and continue. Press esc to stop.